Literature DB >> 28597070

The KISS1 metastasis suppressor appears to reverse the Warburg effect by shifting from glycolysis to mitochondrial beta-oxidation.

Sharon J Manley1, Wen Liu1,2, Danny R Welch3,4.   

Abstract

The shift by cancer cells toward aerobic glycolysis (Warburg effect) confers selective advantages by utilizing nutrients (e.g., lipids, amino acids, and nucleotides) to build biomass. Lipogenesis is generally enhanced, and its inhibition diminishes proliferation and survival. Re-expression of the metastasis suppressor KISS1 in human melanoma cells results in greater mitochondrial biogenesis, inhibition of glycolysis, utilization of beta-oxidation to provide energy, elevated oxidation of exogenous fatty acids, and increased expression of early-phase lipogenesis genes at both mRNA and protein levels. Correspondingly, the energy sensor AMPKβ is phosphorylated, resulting in inhibitory phosphorylation of acetyl-CoA carboxylase (ACC), which is linked to enhanced beta-oxidation. Furthermore, PGC1α is required for KISS1-mediated phosphorylation of ACC and metastasis suppression. Collectively, these data further support the linkages between macromolecular metabolism and metastasis. KEY MESSAGES: • KISS1 alters fatty acid metabolism. • There may be connections between metastasis and metabolism. • PGC1alpha appears to be downstream mediator of KISS1 metastasis suppression.

Entities:  

Keywords:  Glycolysis; KISS1; Lipid metabolism; Metastasis

Mesh:

Substances:

Year:  2017        PMID: 28597070      PMCID: PMC5709182          DOI: 10.1007/s00109-017-1552-2

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  70 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  The AMP-activated protein kinase--fuel gauge of the mammalian cell?

Authors:  D G Hardie; D Carling
Journal:  Eur J Biochem       Date:  1997-06-01

3.  Metastasis suppressor KISS1 seems to reverse the Warburg effect by enhancing mitochondrial biogenesis.

Authors:  Wen Liu; Benjamin H Beck; Kedar S Vaidya; Kevin T Nash; Kyle P Feeley; Scott W Ballinger; Keke M Pounds; Warren L Denning; Anne R Diers; Aimee Landar; Animesh Dhar; Tomoo Iwakuma; Danny R Welch
Journal:  Cancer Res       Date:  2013-12-18       Impact factor: 12.701

4.  Assessment of fatty acid beta oxidation in cells and isolated mitochondria.

Authors:  George W Rogers; Sashi Nadanaciva; Rachel Swiss; Ajit S Divakaruni; Yvonne Will
Journal:  Curr Protoc Toxicol       Date:  2014-05-27

Review 5.  Mouse models of advanced spontaneous metastasis for experimental therapeutics.

Authors:  Giulio Francia; William Cruz-Munoz; Shan Man; Ping Xu; Robert S Kerbel
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

Review 6.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

7.  ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis.

Authors:  Kaori Ishikawa; Keizo Takenaga; Miho Akimoto; Nobuko Koshikawa; Aya Yamaguchi; Hirotake Imanishi; Kazuto Nakada; Yoshio Honma; Jun-Ichi Hayashi
Journal:  Science       Date:  2008-04-03       Impact factor: 47.728

Review 8.  Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism.

Authors:  Paolo E Porporato; Valéry L Payen; Bjorn Baselet; Pierre Sonveaux
Journal:  Cell Mol Life Sci       Date:  2015-12-08       Impact factor: 9.261

9.  Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas.

Authors:  Fernando López-Ríos; María Sánchez-Aragó; Elena García-García; Alvaro D Ortega; José R Berrendero; Francisco Pozo-Rodríguez; Angel López-Encuentra; Claudio Ballestín; José M Cuezva
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

10.  Furin is the major proprotein convertase required for KISS1-to-Kisspeptin processing.

Authors:  Sitaram Harihar; Keke M Pounds; Tomoo Iwakuma; Nabil G Seidah; Danny R Welch
Journal:  PLoS One       Date:  2014-01-13       Impact factor: 3.240

View more
  10 in total

Review 1.  KISS1 in breast cancer progression and autophagy.

Authors:  Ilya V Ulasov; Anton V Borovjagin; Peter Timashev; Massimo Cristofanili; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2019-09       Impact factor: 9.264

Review 2.  Role of the tumor microenvironment in regulating the anti-metastatic effect of KISS1.

Authors:  Sitaram Harihar; Srijit Ray; Samyukta Narayanan; Anirudh Santhoshkumar; Thuc Ly; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2020-02-22       Impact factor: 5.150

Review 3.  Rethinking the biology of metastatic melanoma: a holistic approach.

Authors:  Hendrik Hld Vandyck; Lisa M Hillen; Francesca M Bosisio; Joost van den Oord; Axel Zur Hausen; Véronique Winnepenninckx
Journal:  Cancer Metastasis Rev       Date:  2021-04-19       Impact factor: 9.264

4.  MiR-506 Targets UHRF1 to Inhibit Colorectal Cancer Proliferation and Invasion via the KISS1/PI3K/NF-κB Signaling Axis.

Authors:  Yilin Lin; Zhihua Chen; Yan Zheng; Yisu Liu; Ji Gao; Suyong Lin; Shaoqin Chen
Journal:  Front Cell Dev Biol       Date:  2019-11-15

Review 5.  Roles of mitochondria in the hallmarks of metastasis.

Authors:  Adam D Scheid; Thomas C Beadnell; Danny R Welch
Journal:  Br J Cancer       Date:  2020-11-04       Impact factor: 7.640

Review 6.  The KiSS-1/GPR54 system: Essential roles in physiological homeostasis and cancer biology.

Authors:  Nisha Zhu; Mengxiang Zhao; Yuxian Song; Liang Ding; Yanhong Ni
Journal:  Genes Dis       Date:  2020-07-24

7.  Targeting hepatic kisspeptin receptor ameliorates nonalcoholic fatty liver disease in a mouse model.

Authors:  Stephania Guzman; Magdalena Dragan; Hyokjoon Kwon; Vanessa de Oliveira; Shivani Rao; Vrushank Bhatt; Katarzyna M Kalemba; Ankit Shah; Vinod K Rustgi; He Wang; Paul R Bech; Ali Abbara; Chioma Izzi-Engbeaya; Pinelopi Manousou; Jessie Y Guo; Grace L Guo; Sally Radovick; Waljit S Dhillo; Fredric E Wondisford; Andy V Babwah; Moshmi Bhattacharya
Journal:  J Clin Invest       Date:  2022-05-16       Impact factor: 19.456

Review 8.  ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics.

Authors:  Jun Hou; Changqing Jiang; Xudong Wen; Chengming Li; Shiqiang Xiong; Tian Yue; Pan Long; Jianyou Shi; Zhen Zhang
Journal:  Front Pharmacol       Date:  2022-07-13       Impact factor: 5.988

Review 9.  Novel Insight into the Role of the Kiss1/GPR54 System in Energy Metabolism in Major Metabolic Organs.

Authors:  Xuehan Li; Chunyu Liang; Yi Yan
Journal:  Cells       Date:  2022-10-06       Impact factor: 7.666

10.  Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases.

Authors:  Haarith Ndiaye; Jorlin Y Liu; Andrew Hall; Shane Minogue; Marsha Y Morgan; Mark G Waugh
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.